Table 1.
Rheumatoid Factor Antibodies | COVID (n=129) |
---|---|
Overall prevalence in any RFs, n (%) | 26 (20.16) |
RF-IgA | 13 (10.32) |
RF-IgG | 8 (6.35) |
RF-IgM | 12 (9.52) |
RF-IgA +RF-IgG | 1 (0.78) |
RF-IgA +RF-IgM | 2 (1.55) |
RF-IgG+RF-IgM | 2 (1.55) |
RF-IgA +RF-IgG+RF-IgM | 1 (0.78) |
Note: The cutoff values for positivity in all rheumatoid factor antibodies were set >18 kU/L based on the recommendations of the manufacturer.